Table 1 Pango lineage assignments for participants (P) with SARS-CoV-2 samples sequenced with > 85% genome sequence coverage. S1–3 denotes samples 1–3 across time
Participant | Sample | Lineage |
|---|---|---|
01 | 1 | B.1 |
2 | B.1 | |
02 | 1 | B.1 |
2 | B.1 | |
03 | 1 | B.1 |
2 | B.1 | |
04 | 1 | B.1 |
05 | 1 | B.1 |
2 | B.1.36.1 | |
06 | 1 | B.1 |
2 | B.1 | |
07 | 1 | B.1.36.1 |
2 | B.1.36.1 | |
09 | 1 | B.1 |
2 | B.1 | |
3 | B.1.36 | |
10 | 1 | B.1 |
11 | 3 | B.1 |
12 | 1 | B.1.36.1 |
2 | B.1 | |
13 | 1 | B.1 |
14 | 1 | B.1.36.1 |
15 | 2 | B.1 |
16 | 1 | B.1 |
2 | B.1 |